Finsbury Worldwide Pharm Tst PLC
14 September 2000
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1. Name of company 2. Name of director
Finsbury Worldwide Pharmaceutical Mr Anthony Townsend
Trust PLC
3. Please state whether 4. Name of the registered holder(s)
notification indicates that it is and, if more than one holder, the
in respect of holding of the number of shares held by each of
director named in 2 above or them. (if notified)
holding of that person's spouse or
children under the age.of 18 or in The Corporation of Lloyds
respect of a non-beneficial
interest
Director named in 2 above
5. Please state whether 6. Please state the nature of the
notification relates to a person(s) transaction. For PEP transactions
connected with the director named please indicate whether
in 2 above and identify the general/single co PEP and if
connected person(s) discretionary/non-discretionary
N/A not stated
7. Number of 8. Percentage 9. Number of 10. Percentage
shares/amount of of issued shares/amount of of issued
stock acquired class stock disposed class
nil N/A 441 0.001%
11. Class of 12. Price per 13. Date of 14. Date company
security share transaction informed
25p Ordinary £6.23 14th September 14th September 2000
2000
15) Total holding following this 16) Total percentage holding of
notification issued class following this
notification
206,859 shares 0.53%
If a director has been granted options by the company please complete the
following
boxes.
17. Date of grant 18. Period during which or date on
which exercisable
19. Total amount paid (if any) for 20. Description of shares or
grant of the option debentures involved: class, number
21. Exercise price (if fixed at 22. Total number of shares or
time of grant) or indication debentures over which options
that price is to be fixed at held following this
time of exercise notification
23. Any additional information 24. Name of contact and telephone
number for queries
Nicola Payne
Tel. 020 7426 6214
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.